<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04184271</url>
  </required_header>
  <id_info>
    <org_study_id>2016-11-08</org_study_id>
    <nct_id>NCT04184271</nct_id>
  </id_info>
  <brief_title>Pharmacokinetics of Advantage Arrest</brief_title>
  <official_title>Pharmacokinetics of Advantage Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Advantage Silver Dental Arrest, LLC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Advantage Silver Dental Arrest, LLC</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aim is to characterize the kinetics of silver and fluoride after topical&#xD;
      application of silver diamine fluoride.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to characterize basic PK parameters (Cmax, t1/2, AUC, and total&#xD;
      urinary recovery) to contribute to evidence for the safety of Advantage Arrest, consistent&#xD;
      with Guidance for Industry--Exposure--Response Relationships (April 2003).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2017</start_date>
  <completion_date type="Actual">March 31, 2019</completion_date>
  <primary_completion_date type="Actual">September 30, 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Open label exposure--response study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Observed Fluoride Urinary Recovery</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>24 hour fluoride urinary recovery (in mg)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Silver Tmax</measure>
    <time_frame>baseline, 30 minutes, and 1, 2, 3, 4, 6, 8, 12, and 24 hours</time_frame>
    <description>Observed silver time to maximum serum concentration in hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Silver Cmax</measure>
    <time_frame>baseline, 30 minutes, and 1, 2, 3, 4, 6, 8, 12, and 24 hours</time_frame>
    <description>Observed silver maximum serum concentration in ng/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Silver Baseline-Corrected Cmax</measure>
    <time_frame>baseline, 30 minutes, and 1, 2, 3, 4, 6, 8, 12, and 24 hours</time_frame>
    <description>Observed silver baseline-corrected maximum serum concentration in ng/mL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Silver t1/2</measure>
    <time_frame>baseline, 30 minutes, and 1, 2, 3, 4, 6, 8, 12, and 24 hours</time_frame>
    <description>Observed silver serum elimination half-life in hours</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Observed Silver 24 Hour Urinary Concentration</measure>
    <time_frame>baseline to 24 hours</time_frame>
    <description>Observed silver 24-hour urinary concentration in ng/mL</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Dental Caries</condition>
  <arm_group>
    <arm_group_label>38% silver diamine fluoride</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>38% silver diamine fluoride, topical, 1 drop, single application</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>38% silver diamine fluoride</intervention_name>
    <description>Topical application of SDF to teeth</description>
    <arm_group_label>38% silver diamine fluoride</arm_group_label>
    <other_name>Advantage Arrest</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years or older, minimum 20 teeth, healthy, not taking prescription or OTC&#xD;
             medications&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnant, weighed less than 50 kg, had oral mucositis or ulcerative lesions, known&#xD;
             sensitivity to silver or fluoride&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Milgrom, DDS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Washington Institute of Translational Health Sciences</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Lin YS, Rothen ML, Milgrom P. Pharmacokinetics of 38% topical silver diamine fluoride in healthy adult volunteers. J Am Dent Assoc. 2019 Mar;150(3):186-192. doi: 10.1016/j.adaj.2018.10.018.</citation>
    <PMID>30803490</PMID>
  </results_reference>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>November 28, 2019</study_first_submitted>
  <study_first_submitted_qc>November 30, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 3, 2019</study_first_posted>
  <results_first_submitted>July 7, 2020</results_first_submitted>
  <results_first_submitted_qc>July 31, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">August 14, 2020</results_first_posted>
  <last_update_submitted>January 11, 2021</last_update_submitted>
  <last_update_submitted_qc>January 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>adult</keyword>
  <keyword>fluoride</keyword>
  <keyword>silver</keyword>
  <keyword>silver diamine fluoride</keyword>
  <keyword>pharmacokinetics</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dental Caries</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorides</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>July 30, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/71/NCT04184271/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>November 8, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/71/NCT04184271/Prot_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>38% Silver Diamine Fluoride</title>
          <description>38% silver diamine fluoride, topical, 1 drop, single application&#xD;
38% silver diamine fluoride: Topical application of SDF to teeth</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>38% Silver Diamine Fluoride</title>
          <description>38% silver diamine fluoride, topical, 1 drop, single application&#xD;
38% silver diamine fluoride: Topical application of SDF to teeth</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="41.4" spread="13.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Silver Observed Baseline</title>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.15" spread="0.03"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline Fluoride</title>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Observed Fluoride Urinary Recovery</title>
        <description>24 hour fluoride urinary recovery (in mg)</description>
        <time_frame>baseline to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>38% Silver Diamine Fluoride</title>
            <description>38% silver diamine fluoride, topical, 1 drop, single application&#xD;
38% silver diamine fluoride: Topical application of SDF to teeth</description>
          </group>
        </group_list>
        <measure>
          <title>Observed Fluoride Urinary Recovery</title>
          <description>24 hour fluoride urinary recovery (in mg)</description>
          <units>mg</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.29" spread="0.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Observed Silver Tmax</title>
        <description>Observed silver time to maximum serum concentration in hours</description>
        <time_frame>baseline, 30 minutes, and 1, 2, 3, 4, 6, 8, 12, and 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>38% Silver Diamine Fluoride</title>
            <description>38% silver diamine fluoride, topical, 1 drop, single application&#xD;
38% silver diamine fluoride: Topical application of SDF to teeth</description>
          </group>
        </group_list>
        <measure>
          <title>Observed Silver Tmax</title>
          <description>Observed silver time to maximum serum concentration in hours</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Observed Silver Cmax</title>
        <description>Observed silver maximum serum concentration in ng/mL</description>
        <time_frame>baseline, 30 minutes, and 1, 2, 3, 4, 6, 8, 12, and 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>38% Silver Diamine Fluoride</title>
            <description>38% silver diamine fluoride, topical, 1 drop, single application&#xD;
38% silver diamine fluoride: Topical application of SDF to teeth</description>
          </group>
        </group_list>
        <measure>
          <title>Observed Silver Cmax</title>
          <description>Observed silver maximum serum concentration in ng/mL</description>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.70" spread="0.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Observed Silver Baseline-Corrected Cmax</title>
        <description>Observed silver baseline-corrected maximum serum concentration in ng/mL</description>
        <time_frame>baseline, 30 minutes, and 1, 2, 3, 4, 6, 8, 12, and 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>38% Silver Diamine Fluoride</title>
            <description>38% silver diamine fluoride, topical, 1 drop, single application&#xD;
38% silver diamine fluoride: Topical application of SDF to teeth</description>
          </group>
        </group_list>
        <measure>
          <title>Observed Silver Baseline-Corrected Cmax</title>
          <description>Observed silver baseline-corrected maximum serum concentration in ng/mL</description>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.67" spread="0.49"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Observed Silver t1/2</title>
        <description>Observed silver serum elimination half-life in hours</description>
        <time_frame>baseline, 30 minutes, and 1, 2, 3, 4, 6, 8, 12, and 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>38% Silver Diamine Fluoride</title>
            <description>38% silver diamine fluoride, topical, 1 drop, single application&#xD;
38% silver diamine fluoride: Topical application of SDF to teeth</description>
          </group>
        </group_list>
        <measure>
          <title>Observed Silver t1/2</title>
          <description>Observed silver serum elimination half-life in hours</description>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="46" spread="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Observed Silver 24 Hour Urinary Concentration</title>
        <description>Observed silver 24-hour urinary concentration in ng/mL</description>
        <time_frame>baseline to 24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>38% Silver Diamine Fluoride</title>
            <description>38% silver diamine fluoride, topical, 1 drop, single application&#xD;
38% silver diamine fluoride: Topical application of SDF to teeth</description>
          </group>
        </group_list>
        <measure>
          <title>Observed Silver 24 Hour Urinary Concentration</title>
          <description>Observed silver 24-hour urinary concentration in ng/mL</description>
          <units>ng/mL</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="16"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.05" lower_limit="0.05" upper_limit="0.06"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 hours</time_frame>
      <group_list>
        <group group_id="E1">
          <title>38% Silver Diamine Fluoride</title>
          <description>38% silver diamine fluoride, topical, 1 drop, single application&#xD;
38% silver diamine fluoride: Topical application of SDF to teeth</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Peter Milgrom</name_or_title>
      <organization>Advantage Silver Dental Arrest, LLC</organization>
      <phone>2062516831</phone>
      <email>drmilgrom@silverarrest.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

